Skip to main content

Lluis Castells Fusté

Institutions of which they are part

Senior researcher
Liver Diseases
Vall Hebron Institut de Recerca

Lluis Castells Fusté

Institutions of which they are part

Senior researcher
Liver Diseases
Vall Hebron Institut de Recerca

Projects

Malalties hepàtiques

IP: Joan Genescà Ferrer
Collaborators: Beatriz Minguez Rosique, Sergi Colomer Castell, Elena Vargas Accarino, Immaculada Raurell Saborit, Lluís Viladomiu Catà, Lluis Castells Fusté, Maria del Mar Riveiro Barciela, Maria Buti Ferret, Malalties hepàtiques, Judit Romero Vico, Josep Quer Sivila, Malalties hepàtiques, Juan Manuel Pericas Pulido, Malalties hepàtiques, Malalties hepàtiques, Laura Puente Ramo, Isabel Campos Varela, Malalties hepàtiques, Juan Ignacio Esteban Mur, Ester Palacio Gutierrez, Susana Anton Calvo, Monica Higuera Urbano, Meritxell Ventura Cots, Ares Aurora Villagrasa Vilella, Emma Bigas Alsina, Carolina Campos Martinez, Macarena Simon-Talero Horga, David Tabernero Caellas, Mònica Pons Delgado, Marcella Salzano
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 00462
Duration: 01/01/2022 - 30/06/2025

TRANS-GENE - Caracterización en Sangre Periférica de una Firma Génica de Rechazo Humoral Común en Trasplantes de Órganos Sólidos.

IP: Maria Antonia Emilia Meneghini
Collaborators: Saskia Natali Agámez Luengas, Lluis Castells Fusté, Joana Sellarés Roig, Jesús Quintero Bernabeu, Eva Maria Revilla Lopez, Marina Muñoz López, Meritxell Boada Perez, Laura Donadeu Casassas, Mercedes López González
Funding agency: Instituto de Salud Carlos III
Funding: 111320
Reference: PI22/00749
Duration: 01/01/2023 - 31/12/2026

Evaluación de la sarcopenia en pacientes con cirrosis hepática mediante bioimpedancia y ecografía de muslo

IP: Isabel Campos Varela
Collaborators: Lluis Castells Fusté, Nuria Roson Gradaille, Ernest Hidalgo Llompart
Funding agency: Instituto de Salud Carlos III
Funding: 84095
Reference: PI19/00330
Duration: 01/01/2020 - 30/06/2024

Identificación de marcadores de diagnóstico y pronóstico de carcinoma hepatocelular (HCC) en vesiculas extracelulares, mediante un método mínimamente invasivo, basado en secuenciación masiva (NGS)

IP: Josep Quer Sivila
Collaborators: Itxarone Izaskun Bilbao Aguirre, Lluis Castells Fusté, Ariadna Rando Segura
Funding agency: Instituto de Salud Carlos III
Funding: 165770
Reference: PI19/00301
Duration: 01/01/2020 - 30/06/2023

Related news

The results, published in The Lancet and Nature Medicine, provide new evidence to improve the diagnosis of metabolic dysfunction-associated steatotic liver disease and reduce the need for liver biopsies.

The CHANCE study analyzes the outcomes of nearly 1,000 patients at 63 liver transplant centers and identifies which patients with the most severe forms of the disease may benefit from transplantation.

The grants support projects led by Drs. María José Buzón, María Buti, Elena Élez, and Maria Vieito.

Related professionals

Maria Acevedo Alonso

Maria Acevedo Alonso

Research technician
Pneumology
Read more
Laura Grossi Garriga

Laura Grossi Garriga

Research technician
Physical Medicine and Rehabilitation
Read more
Maria Roch Santed

Maria Roch Santed

Predoctoral researcher
Basic, Translational and Clinical Pharmacy Research
Read more
Aitana Diaz Vazquez

Aitana Diaz Vazquez

Research technician
Clinical and Translational Bioinformatics
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.